期刊文献+

靶向人端粒酶反转录酶RNA干扰载体质粒的构建与筛选

Construction and screening of RNAi vector plasmids targeting human telomerase reverse transcriptase
下载PDF
导出
摘要 目的:设计靶向人端粒酶反转录酶的RNAi序列,构建shRNA表达载体质粒和hTERT真核表达质粒,采用共转染工具细胞筛选出有效靶点。方法:首先以EASYTMsiRNA软件针对hTERT设计5个靶点siRNA序列和1条通用阴性对照序列,合成shRNA oligo表达框架,将其分别连接至经酶切消化的载体质粒、pGCsi-U6/Neo/GFP、pGCL-GFP,重组质粒转化DH5α,阳性克隆进行PCR与测序鉴定;然后从cDNA文库中利用PCR钓取hTERT基因片段,与表达载体pEGFP-C1分别进行双酶切、纯化及定向连接、重组、转化,阳性克隆行PCR与测序鉴定,荧光镜检GFP表达;最后上述2个质粒系统共转染293T细胞,Western印迹检测hTERT蛋白表达水平,筛选最有效序列。应用SPSS16.0软件包对所得数据进行单因素方差分析。结果:BLAST检索5条hTERT siRNA序列均能100%命中,且不与其他基因同源;PCR鉴定及阳性克隆测序验证shRNA oligo与载体质粒成功连接、重组。hTERT基因PCR钓取片段产物大小1.4 Kp,经酶切与质粒连接,形成pEGFP-C1-hTERT表达载体,阳性克隆PCR、测序鉴定确定成功重组;转染293T细胞48h时荧光镜下可观察到GFP标记的hTERT融合蛋白。hTERT表达质粒和shRNA载体质粒共转染293T细胞,48h时Western印迹检测结果显示:实验各组hTERT蛋白量均有不同程度减少,而内参对照β-actin和GAPDH无明显变化。经β-actin校正,得到各组hTERT蛋白相对表达量:KD No.1-5实验组与NC组相比,hTERT基因表达均得到不同程度的敲减(54.61%~76.84%,P<0.05),其中No.4敲减效能最高。结论:5条RNAi设计序列均可有效、特异性地沉默hTERT基因的转录和表达水平,其中以5’-GCAAGTTGCAAAGCATTGGAA-3’敲减效能最优;构建外源基因的过表达载体质粒转染工具细胞,可作为RNAi敲减效率筛选的验绩标靶。 PURPOSE: To design RNAi sequences targeting hTERT and to construct hTERT-shRNA vector plasmids and hTERT eukaryotic expression plasmid. To screen the most efficient knock-down sequence by co-transfection of two plasmids above to 293T cells. METHODS: First, five siRNA sequences targeting hTERT and one general negative control sequence were designed by EASyTMsiRNA. The 6 shRNA oligo expression frames were synthesized and linked into vector plasmids, pGCsi-U6/Neo/GFP and pGCL-GFP, which contained U6 promoter, respectively. The recombinant vectors were transformed into competent cells, DH5α, and were identified by PCR and sequencing of positive clones. Then, hTERT gene segment was obtained by PCR from cDNA library. Double digested hTERT gene segment was inserted into pEGFP- C1 vector and was confirmed by PCR and sequencing after transformed into competent cell. GFP expression was detected by fluoroscope at 48 hour when pEGFP-C1-hTERT was transfected into 293T cells. Finally, total proteins were extracted from 293T cells co-transfected by shRNA expression and hTERT expression vector plasmids at 48 hour. HTERT protein was detected by Western blot. hTERT protein gray scale values were calibrated by β-actin, SPSSTM v16.0 software package was used for one-way ANOVA to judge different knock-down efficiency of different target sites in which the most potent one was chosen as the consequent experiments' sequence. RESULTS: In BLAST searching, all five designed siRNA sequences were 100% specially targeted hTERT transcript variant 1 and had no homology with any other genes. The general negative control sequence had no homology with any genes. The six synthesized shRNA double strains frames with cohesive ends were correctly inserted and recombinated into vectors above, respectively, indentified by PCR and sequencing of Amp-screened positive clones picked from competent cell transformation. Agarose gel electrophoresis results affirmed double digested hTERT gene segment, 1.4 kp, and pEGFP-C1, 4.7 kb, both concorded to expectation, hTERT gene segment was correctly inserted and recombinated into pEGFP-C1 indentified by PCR and sequencing. At 48 hour under fluoroscope, GFP could efficiently express in 293T cells transfected by pEGFP-CI-hTERT. Western blot results of 293T cells co-transfected by hTERT overexpression and hTERT shRNA plasmids at 48 hour showed all candidate sequences could specially down-regulate the hTERT protein level in different degrees while the inner control protein level, β-actin and GAPDH, did not change. Calibrated by β-actin, No.1-5 KD groups' hTERT protein levels, compared'with NC group, were knocked down by 54.61%-76.84%(P〈0.05), among five groups No.4 reached to the highest potency (P〈 0.05). CONCLUSION: All five candidate RNAi sequences could specially and effectively knock down hTERT, and the 5'-GCAAGTFGCAAAGCATFGGAA-3' showed the most potent, so it was chosen as the consequent experiments' sequence. Cells transfected with exogenous gene expressing vector plasmid could set as knock-down efficiency testing targets for RNAi sequences screening. Supported by National Natural Science Foundation of China (Grant No. 30672333) and Natural Science Foundation of Guangdong Province (Grant No. 06104607).
出处 《中国口腔颌面外科杂志》 CAS 2008年第6期435-443,共9页 China Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金(30672333) 广东省自然科学基金(06104607)~~
关键词 RNA干扰 人端粒酶反转录酶 质粒构建 基因转染 RNA interference RNAi Human telomerase reverse transcriptase Plasmid construction Gene transfection
  • 引文网络
  • 相关文献

参考文献16

  • 1[1]Lee SR,Wong JM,Collins K.Human telomerase reverse transcriptase motifs required for elongation of a telomeric substrate[J].J Biol Chem,2003,278(52):52531-52536.
  • 2[2]Calcagnile O,Gisselsson D.Telomere dysfunction and telomerase activation in cancer-a pathological paradox[J]?Cytogenet Genome Res,2007,118(2-4):270-276.
  • 3[3]Kannan S,Tahara H,Yokozaki H.et al.Telomerase activity in premalignant and malignant lesions of human oral mucosa[J].Cancer Epidemiol Biomarkers Prey,1997,6(6):413-420.
  • 4[4]Timmons L,Tabara H,Mello CC,et al,Inducible systemic RNA silencing in Caenorhabditis elegans[J].Mol Biol Cell,2003,14(7):2972-2983.
  • 5[5]Blackburn EH,Greider CW,Szostak JW.Telomeres and telomerase:the path from maize,tetrahymena and yeast to human eaneer and aging[J].Nat Med,2006,12(10):7-12.
  • 6[6]Cerone MA,Ward RJ,Londofio-allejo JA,et al.Telomerase RNA mutated in autosomal dvskerat,,sis congenita reconstilutes a weakly active telomerase Pnzyme deftctive in telomere elongation[J].Cell Cycle,2005,4(4):585-589.
  • 7[7]Kelland LR.Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutioS-current status and future prospects[J].Eur J Cancer,2005,41(7):971-979.
  • 8刘习强,黄洪章,张彬,等.人端粒酶反转录酶基因与P53途径调控蛋白在舌鳞癌中的表达及其相关性分析[J].中华口腔医学研究杂志,2007,1(1):11-14.
  • 9冯元勇,李宁毅,贾暮云,周晓健,张萍,陈万涛.大鼠颊黏膜鳞癌细胞系端粒酶活性与其转移相关性的研究[J].中国口腔颌面外科杂志,2007,5(3):200-203. 被引量:2
  • 10[10]Phatak P,Burger A M.Telomerase and its potential for therapeutic intervention[J].Br J Pharmacol,2007,152(7):1003-1011.

二级参考文献21

  • 1Jian-lun Liu,Lian-ying Ge,Gui-nian Zhang.Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma[J].World Journal of Gastroenterology,2006,12(3):465-467. 被引量:11
  • 2秦兴军,张恩礁,杨捷琳,王绪凯,孙长伏,李瑞武,关晓峰.应用抑制性消减杂交技术分析涎腺腺样囊性癌转移相关基因[J].中国医科大学学报,2006,35(4):392-394. 被引量:5
  • 3[1]Guan XF,Qiu WL,He RG,et al.Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung:an experimental study[J].In J Oral Maxillofac Surg,1997,26:116-119.
  • 4[3]Zendman AJ,van Kraats AA,den Hollander AI,et al.Characterization of XAGE-1b,a short major transcript of cancer/testis-associated gene XAGE-1,induced in melanoma metastasis[J].Int J Cancer,2002,97(2):195-204.
  • 5[4]Van der Bruggen P,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254:1643-1647.
  • 6[5]Old LJ.Cancer immunology:the search for specificity.G.H.A.Clowes Memorial lecture[J].Cancer Res,1981,41:361-375.
  • 7[6]Boel P,Wildmann C,Sensei ML,et al.BAGE:a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes[J].Immuntity,1995,2:167-175.
  • 8[7]Van den Eynde B,Peeters O,de Backer O,et al.A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma[J].J Exp Med,1995,182:689-698.
  • 9[8]Tureci O,Sahin U,Vollmar E,et al.Human carbonic anhydrase Ⅻ:cDNA cloning,expression,and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers[J].Proc Natl Acad Sci USA,1998,95:7608-7613.
  • 10Fujimoto R,Kamata N,Yokoyama K,et al.Expression of telomerase components in oral keratinocytes and squamous cell carcinomas.Oral Oncol,2001,37:132-140.

共引文献10

;
使用帮助 返回顶部